First Heart Attack Alerting Technology Launched in Australia

Hydrix Limited in partnership with Angel Medical Systems (AngelMed) has unveiled its plans to launch Guardian, the first heart attack alerting technology in Australia.

Guardian is an implanted cardiac monitoring device to notify patients in case of an imminent Acute Coronary Syndrome (ACS) event such as heart attacks and unstable angina.

It's designed for patients with a history of ACS and who are at high risk for recurrent events.

With the device, there's continuous monitoring of a patient's heart signal and it leverages artificial intelligence to detect an impending heart attack.

Upon identification of suspicious heart activity, the AngelMed Guardian System immediately alerts the patient to seek medical attention with the implant vibrating within the chest and a separate wireless pager-like device alerting with sound and flashing LEDs.

The Guardian implant detects ACS symptoms accurately than the patient and is meant to minimize the uncertainty associated with self-diagnosis.

Around 900 patients were implanted with the device in clinical trials. The data showed lower morbidity rates, improved patient quality of life, decrease in heart damage and hospital stay lowering patient healthcare costs.

The Guardian System is expected to launch in 2021, subject to regulatory approval.